AGP Picks
View all

New Hampshire STEM News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on New Hampshire STEM News.

Press releases published on September 17, 2026

Telomir Announces Peer-Reviewed Publication Showing Telomir-Zn Restores Visual Function and Retinal Structure in a Model of Age-Related Macular Degeneration (AMD)
iMTC Technology Selects SEALSQ TPM183 for Next-Generation Fingerprint Recognition Medical Mouse
SPARC AI Inc.’s (OTC: SPAIF) Software-Defined, Per-Device Model Places Company at Front of Next-Gen Geolocation, Targeting
Capricor Therapeutics to Present HOPE-3 and HOPE-3 Open-Label Extension Data at 2026 World Muscle Society Congress
PharmAla Biotech Provides Corporate Update: Change of Auditor, Retention of Watertower Research and Oak Hill
Forge Nano Expands Partnership with Battery AI Software Leader Voltaiq to Put AI at the Center of Battery Development and Manufacturing
Sol-Gel Technologies Announces Last Patient Last Visit in Pivotal Phase 3 Clinical Trial of SGT-610 in Gorlin Syndrome
EVA DEFENSE UNVEILS NEXT-GENERATION LOW-NOISE AUTONOMOUS DRONE PROTOTYPE DESIGNED FOR STEALTH-ORIENTED OPERATIONS
Delinea Joins Anthropic's Project Glasswing
Matisse Pharmaceuticals closed Series A financing round to advance isupartob sodium through phase 2 clinical development
Aerska Appoints Laura Sepp-Lorenzino to Scientific Advisory Board
Aikido achieves AWS Security Competency for Application Security
Synack CTO to Present Five Tests for Production-Ready AI Pentesting at Gartner® Security & Risk Management Summit
Recludix Pharma to Present at the Stifel 2026 Virtual Immunology and Inflammation Forum
Glacier Fresh Redefines Home Filtration with U03 Tankinside RO System, Solving Industry’s First-Cup TDS Spike Dilemma
Traction Rec Introduces Fresh, a New Era of Technology for Community Recreation, at YMCA General Assembly 2026
NeOnc Technologies Redeems All Outstanding Series A Convertible Preferred Stock and Eliminates Related Potential Dilution
Hemab Therapeutics Announces First Participant Dosed in Phase 1 Clinical Trial of HMB-003, an Investigational Therapy for the Management of Heavy Menstrual Bleeding
Quince Therapeutics to Host Virtual KOL Event to Discuss the Current Treatment Landscape for PH-ILD and BOS and the Role for LAM-001 as a Potential Therapeutic Option on September 28, 2026
Artiva Biotherapeutics to Participate in the Stifel 2026 Virtual Immunology and Inflammation Forum

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

New Hampshire STEM News

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.